C12Y 305/04001
Cytosine deaminase
Official title: Cytosine deaminase (3.5.4.1)
C12Y305/04001 (Cytosine deaminase) appears on 64 US grants and 172 published applications in this corpus.
Search patents in C12Y- Granted patents
- 64
- Published applications
- 172
- Assignees
- 103
- Inventors
- 391
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 3 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 3 | 4 |
| 2015 | 2 | 13 |
| 2016 | 3 | 4 |
| 2017 | 4 | 2 |
| 2018 | 5 | 4 |
| 2019 | 3 | 8 |
| 2020 | 1 | 12 |
| 2021 | 5 | 12 |
| 2022 | 3 | 18 |
| 2023 | 7 | 14 |
| 2024 | 8 | 19 |
| 2025 | 8 | 22 |
| 2026 | 7 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for modulating RNA splicing by inducing base mutation at splice site or base substitution in polypyrimidine region6 Oct 2026US 12,753,420 B2Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
- Fusion protein that improves gene editing efficiency and application thereof7 Jul 2026US 12,674,154 B2BRL Medicine (Shanghai) Co., Ltd.
- AAV delivery of nucleobase editors30 Jun 2026US 12,668,815 B2President and Fellows of Harvard College
- Systems, methods, and compositions for targeted nucleic acid editing16 Jun 2026US 12,655,403 B2
- Selective curbing of unwanted RNA editing (SECURE) DNA base editor variants19 May 2026US 12,630,821 B2The General Hospital Corporation
- Base editing approaches to treat abca4-associated stargardt disease8 Oct 2026US 2026/0306670 A1Massachusetts Eye and Ear Infirmary
- System, Kit, and Method for Continuous Directed Evolution8 Oct 2026US 2026/0308569 A1The Board of Trustees of the University of Illinois
- Ultracompact precision editing systems and uses thereof3 Sep 2026US 2026/0258382 A1Mammoth Biosciences, Inc.
- Artificial intelligence-mediated methods and systems for genome editing3 Sep 2026US 2026/0260707 A1Pioneer Hi-Bred International, Inc.
- SPLICER: A Highly Efficient Base Editing Toolbox That Enables In Vivo Therapeutic Exon Skipping27 Aug 2026US 2026/0250656 A1The Brd. of Trustees of the Univ. of Illinois
Most cited
By later US patents
- Methods for correcting presenilin point mutations123US 9,068,179 B1President and Fellows of Harvard College · 2015
- Methods for nucleic acid editing121US 9,840,699 B2President and Fellows of Harvard College · 2017
- Fusions of Cas9 domains and nucleic acid-editing domains74US 11,053,481 B2President and Fellows of Harvard College · 2021
- Cas variants for gene editing73US 11,124,782 B2President and Fellows of Harvard College · 2021
- Cas variants for gene editing72US 10,465,176 B2President and Fellows of Harvard College · 2019